These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3419426)

  • 1. Inhibition of glucokinase by alloxan through interaction with SH groups in the sugar-binding site of the enzyme.
    Lenzen S; Freytag S; Panten U
    Mol Pharmacol; 1988 Sep; 34(3):395-400. PubMed ID: 3419426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alloxan and ninhydrin inhibition of hexokinase from pancreatic islets and tumoural insulin-secreting cells.
    Lenzen S; Freytag S; Panten U; Flatt PR; Bailey CJ
    Pharmacol Toxicol; 1990 Mar; 66(3):157-62. PubMed ID: 2185463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition.
    Lenzen S; Brand FH; Panten U
    Br J Pharmacol; 1988 Nov; 95(3):851-9. PubMed ID: 3207996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of alloxan on islet tissue permeability: protection and reversal by dithiols.
    Watkins D; Cooperstein SJ
    J Pharmacol Exp Ther; 1976 Dec; 199(3):575-82. PubMed ID: 792416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of cysteine residues for the stability and catalytic activity of human pancreatic beta cell glucokinase.
    Tiedge M; Richter T; Lenzen S
    Arch Biochem Biophys; 2000 Mar; 375(2):251-60. PubMed ID: 10700381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of human glucokinase intrinsic activity by SH reagents mirrors post-translational regulation of enzyme activity.
    Tiedge M; Krug U; Lenzen S
    Biochim Biophys Acta; 1997 Feb; 1337(2):175-90. PubMed ID: 9048894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glucokinase in hepatocytes by alloxan.
    Miwa I; Hara H; Matsunaga H; Okuda J
    Biochem Int; 1984 Nov; 9(5):595-602. PubMed ID: 6240981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucokinase in pancreatic B-cells and its inhibition by alloxan.
    Lenzen S; Tiedge M; Panten U
    Acta Endocrinol (Copenh); 1987 May; 115(1):21-9. PubMed ID: 3296598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of aconitase by alloxan and the differential modes of protection of glucose, 3-O-methylglucose, and mannoheptulose.
    Lenzen S; Mirzaie-Petri M
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Nov; 346(5):532-6. PubMed ID: 1470224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of glucokinase as an alloxan-sensitive glucose sensor of the pancreatic beta-cell.
    Meglasson MD; Burch PT; Berner DK; Najafi H; Matschinsky FM
    Diabetes; 1986 Oct; 35(10):1163-73. PubMed ID: 3530846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
    Gai W; Schott-Ohly P; Schulte im Walde S; Gleichmann H
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):29-37. PubMed ID: 14758569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dithiothreitol on protein activity unrelated to thiol-disulfide exchange: for consideration in the analysis of protein function with Cleland's reagent.
    Alliegro MC
    Anal Biochem; 2000 Jun; 282(1):102-6. PubMed ID: 10860505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of cysteine desulfurase Slr0387 from Synechocystis sp. PCC 6803: kinetic analysis of cleavage of the persulfide intermediate by chemical reductants.
    Behshad E; Parkin SE; Bollinger JM
    Biochemistry; 2004 Sep; 43(38):12220-6. PubMed ID: 15379560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of rat liver glucokinase by alloxan and ninhydrin.
    Hara H; Miwa I; Okuda J
    Chem Pharm Bull (Tokyo); 1986 Nov; 34(11):4731-7. PubMed ID: 3829189
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells.
    Rampersad GC; Suck G; Sakac D; Fahim S; Foo A; Denomme GA; Langler RF; Branch DR
    Transfusion; 2005 Mar; 45(3):384-93. PubMed ID: 15752156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenical-based affinity chromatography of vicinal dithiol-containing proteins: purification of L1210 leukemia cytoplasmic proteins and the recombinant rat c-erb A beta 1 T3 receptor.
    Kalef E; Walfish PG; Gitler C
    Anal Biochem; 1993 Aug; 212(2):325-34. PubMed ID: 8214573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of alloxan on the islets of Langerhans. Possible mechanisms of diabetogenic action.
    Borg LA
    Acta Biol Med Ger; 1981; 40(1):71-6. PubMed ID: 7020307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thiols and neuronal nitric oxide synthase: complex formation, competitive inhibition, and enzyme stabilization.
    Gorren AC; Schrammel A; Schmidt K; Mayer B
    Biochemistry; 1997 Apr; 36(14):4360-6. PubMed ID: 9100033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper (II) ions affect Escherichia coli membrane vesicles' SH-groups and a disulfide-dithiol interchange between membrane proteins.
    Kirakosyan G; Trchounian K; Vardanyan Z; Trchounian A
    Cell Biochem Biophys; 2008; 51(1):45-50. PubMed ID: 18458828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose.
    Board M; Colquhoun A; Newsholme EA
    Cancer Res; 1995 Aug; 55(15):3278-85. PubMed ID: 7614462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.